Press Releases Latest Dec 06, 2021 Theratechnologies Submits Supplemental Biologics License Application to FDA Advancing Development of IV Push Trogarzo® for Patients Living With HIV Press Releases Year None202120202019201820172016201520142013 Jul 15, 2020 Theratechnologies Announces Financial Results For The Second Quarter Of Fiscal 2020 Jul 07, 2020 Theratechnologies Confirms Bioequivalence Of New Tesamorelin Formulation Jul 06, 2020 Theratechnologies Announces Ibalizumab Inhibits HIV-2 In Vitro Jun 26, 2020 Theratechnologies To Announce Financial Results For Second Quarter 2020 Jun 22, 2020 New Data Show Theratechnologies’ SORT1+ Technology Is Effective In Many Treatment-Resistant Cancers May 15, 2020 Theratechnologies Unveils New Positive Data For Its Investigational Peptide-Drug Conjugates Targeting Sortilin Positive Cancers May 12, 2020 Theratechnologies To Present At The RBC Capital Markets Global Healthcare Conference On May 19, 2020 Apr 27, 2020 Theratechnologies Announces New Positive Results For Two Investigational Peptide-Drug Conjugates Targeting Sortilin Positive Ovarian Cancer Apr 16, 2020 Theratechnologies Announces Inducement Grants Under NASDAQ Listing Rule 5635(C)(4) Apr 16, 2020 Theratechnologies To Make Oral Presentation On Oncology Platform During AACR Virtual Annual Meeting First page « Previous page ‹ … Page 3 Page 4 Page 5 Page 6 Current page 7 Page 8 Page 9 Page 10 Page 11 … Next page › Last page » Displaying 61 - 70 of 268
Dec 06, 2021 Theratechnologies Submits Supplemental Biologics License Application to FDA Advancing Development of IV Push Trogarzo® for Patients Living With HIV
Jun 22, 2020 New Data Show Theratechnologies’ SORT1+ Technology Is Effective In Many Treatment-Resistant Cancers
May 15, 2020 Theratechnologies Unveils New Positive Data For Its Investigational Peptide-Drug Conjugates Targeting Sortilin Positive Cancers
May 12, 2020 Theratechnologies To Present At The RBC Capital Markets Global Healthcare Conference On May 19, 2020
Apr 27, 2020 Theratechnologies Announces New Positive Results For Two Investigational Peptide-Drug Conjugates Targeting Sortilin Positive Ovarian Cancer
Apr 16, 2020 Theratechnologies To Make Oral Presentation On Oncology Platform During AACR Virtual Annual Meeting
